Australia's Analytica set for best day in 5 weeks after PeriCoach trial results

Analytica

20/11/2020 02:53

** Shares of medical device maker Analytica Ltd  ALT.AX 
rise as much as 50% to A$0.003, posting their biggest intraday
percentage gain since Oct. 15 
    ** Co says an independent clinical trial showed its
PeriCoach device was effective in reducing stress urinary
incontinence (SUI) symptoms in women  urn:newsml:reuters.com:*:nASX8rV2MQ
    ** PeriCoach is a pelvic floor biofeedback device that
guides women to strengthen the muscles of the pelvic floor
    ** Stock hits its highest since Nov. 2; down 33.3% this
year, as of last close

 (Reporting by Nikhil Subba in Bengaluru)
 ((Nikhil.Subba.thomsonreuters.com@reuters.net))